GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Inventories, Inventories Adjustments

ME Therapeutics Holding (XCNQ:METX) Inventories, Inventories Adjustments : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Inventories, Inventories Adjustments?

ME Therapeutics Holding's Inventories, Inventories Adjustments for the quarter that ended in Feb. 2024 was C$0.00 Mil.


ME Therapeutics Holding Inventories, Inventories Adjustments Historical Data

The historical data trend for ME Therapeutics Holding's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Inventories, Inventories Adjustments Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Inventories, Inventories Adjustments
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Inventories, Inventories Adjustments Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines